BEACON Trial: Triplet Therapy in BRAF V600E–Mutated mCRC

preview_player
Показать описание
Johanna C. Bendell, MD, and Tanios Bekaii-Saab, MD, discuss the implications of the BEACON study, which makes use of a novel triplet combination for patients with metastatic colorectal cancer (mCRC).
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
BEACON Trial: Triplet 0:06:01

BEACON Trial: Triplet Therapy in BRAF V600E–Mutated mCRC

Triplet Therapy for 0:00:54

Triplet Therapy for Certain Patients with Metastatic CRC Shows Promise, But More Research is Needed

Triplet Regimens in 0:07:02

Triplet Regimens in BRAF-Mutant Metastatic CRC

Safety Lead-In Data 0:01:18

Safety Lead-In Data for BEACON CRC Trial With Triplet Biologic Regimen in mCRC

BEACON CRC: first-line 0:08:16

BEACON CRC: first-line bevacizumab in colorectal cancer treatment

Dr. Kopetz on 0:01:09

Dr. Kopetz on Updated Data From BEACON CRC Study in BRAF V600E–Mutant CRC

BEACON: Encorafenib plus 0:05:04

BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic ......

Triplet Regimen Improves 0:02:07

Triplet Regimen Improves Responses in BRAF V600E+ Metastatic CRC

Next Steps After 0:00:49

Next Steps After Phase III BEACON CRC Trial in mCRC

Dr. Kopetz on 0:01:11

Dr. Kopetz on the Rationale for the BEACON CRC Study in BRAF V600E-Mutant mCRC

Dr. Kopetz on 0:00:54

Dr. Kopetz on Safety Data From BEACON CRC Trial in BRAF V600E-Mutant mCRC

Dr. Flaherty on 0:01:32

Dr. Flaherty on the Rationale to Explore Triplet Therapy in BRAF V600E-Mutant Melanoma

Dr. Eng Discusses 0:01:51

Dr. Eng Discusses the BEACON CRC Study in BRAF-Mutated CRC

Grothey Shares Encouraging 0:01:18

Grothey Shares Encouraging Data from Lead-In Phase of BEACON CRC Trial

BREAKWATER: encorafenib plus 0:01:45

BREAKWATER: encorafenib plus cetuximab in patients with BRAF V600E-mutant mCRC

Dr. Kopetz Discusses 0:01:00

Dr. Kopetz Discusses Triplet Therapy for BRAF-Mutant CRC

First-Line Triplet in 0:03:25

First-Line Triplet in BRAF+ mCRC

Dr. Kopetz on 0:01:54

Dr. Kopetz on the Rationale and Primary Endpoints of the BEACON CRC Study in mCRC

Scott Kopetz, MD, 0:01:35

Scott Kopetz, MD, shares updates from the BEACON trial in BRAF-mutant colorectal cancer

Dr. Nelson on 0:01:05

Dr. Nelson on QoL Data From the BEACON CRC Trial in mCRC

Stefan Kasper, MD, 0:00:58

Stefan Kasper, MD, provides updates on the BEACON trial in BRAF-mutant CRC

ASCO: Binimetinib-Containing Triplet 0:05:46

ASCO: Binimetinib-Containing Triplet Therapy for BRAF V600E Metastatic Colorectal Cancer

Updated Survival Data 0:01:02

Updated Survival Data from BEACON CRC Lead to More Specific Questions

Dr. Bekaii-Saab on 0:02:06

Dr. Bekaii-Saab on the Impact of the BEACON CRC Study in BRAF-Mutated CRC